---
title: '2022'
date: 2022-24-01
image: "images/gen/services/old-books-arrangement-with-copy-space.jpg"
---

# 2022

1. Nanobodies targeting ABCC3 for immunotargeted applications in glioblastoma.
Ruiz-López E, Jovčevska I, González-Gómez R, Tejero H, Al-Shahrour F, Muyldermans S, Schuhmacher AJ Sci Rep. 2022 Dec 30;12(1):22581. doi: 10.1038/s41598-022-27161-3. PMID: 36585418; PMCID: PMC9803684.

1. CALR-mutated cells are vulnerable to combined inhibition of the proteasome and the endoplasmic reticulum stress response.
Jutzi JS, Marneth AE, Jiménez-Santos MJ, Hem J, Guerra-Moreno A, Rolles B, Bhatt S, Myers SA, Carr SA, Hong Y, Pozdnyakova O, van Galen P, Al-Shahrour F, Nam AS, Mullally A.  Leukemia. 2022 Dec 6. doi: 10.1038/s41375-022-01781-0. Epub ahead of print. PMID: 36473980.

1. Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A.
Mouron S, Bueno MJ, Lluch A, Manso L, Calvo I, Cortes J, Garcia-Saenz JA, Gil-Gil M, Martinez-Janez N, Apala JV, Caleiras E, Ximénez-Embún P, Muñoz J, Gonzalez-Cortijo L, Murillo R, Sánchez-Bayona R, Cejalvo JM, Gómez-López G, Fustero-Torre C, Sabroso-Lasa S, Malats N, Martinez M, Moreno A, Megias D, Malumbres M, Colomer R, Quintela-Fandino M. Nat Commun. 2022 Dec 7;13(1):7529. doi: 10.1038/s41467-022-35065-z. PMID: 36477027.

1.  3D chromatin connectivity underlies replication origin efficiency in mouse embryonic stem cells.
Jodkowska K, Pancaldi V, Rigau M, Almeida R, Fernández-Justel JM, Graña-Castro O, Rodríguez-Acebes S, Rubio-Camarillo M, Carrillo-de Santa Pau E, Pisano D, Al-Shahrour F, Valencia A, Gómez M, Méndez J. Nucleic Acids Res. 2022 Nov 28;50(21):12149-12165. doi: 10.1093/nar/gkac1111. PMID: 36453993; PMCID: PMC9757045.

1. Bioinformatics roadmap for therapy selection in cancer genomics.
Jiménez-Santos MJ, García-Martín S, Fustero-Torre C, Di Domenico T, Gómez-López G, Al-Shahrour F.  Mol Oncol. 2022 Nov;16(21):3881-3908. doi: 10.1002/1878-0261.13286. Epub 2022 Aug 20. PMID: 35811332; PMCID: PMC9627786.

1. Excess weight and anti-PD-1 immune checkpoint inhibitor's outcomes in non-small cell lung cancer.
Rogado J, Pozo F, Troulé K, Sánchez-Torres JM, Romero-Laorden N, Mondejar R, Donnay O, Ballesteros A, Pacheco-Barcia V, Aspa J, Al-Shahrour F, Alfranca A, Colomer R. Clin Transl Oncol. 2022 Nov;24(11):2241-2249. doi: 10.1007/s12094-022-02887-8. Epub 2022 Jul 23. PMID: 35870091.

1. Origins and evolution of human tandem duplicated exon substitution events.
Martinez-Gomez L, Cerdán-Vélez D, Abascal F, Tress ML. Genome Biol Evol. 2022 Nov 8:evac162. doi: 10.1093/gbe/evac162. Epub ahead of print. PMID: 36346145.

1. Clinical variant interpretation and biologically relevant reference transcripts.
Pozo F, Rodriguez JM, Vázquez J, Tress ML. NPJ Genom Med. 2022 Oct 18;7(1):59. doi: 10.1038/s41525-022-00329-6. PMID: 36257961; PMCID: PMC9579139.

1. Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants.
Kayumi S, Pérez-Jurado LA, Palomares M, Rangu S, Sheppard SE, Chung WK, Kruer MC, Kharbanda M, Amor DJ, McGillivray G, Cohen JS, García-Miñaúr S, van Eyk CL, Harper K, Jolly LA, Webber DL, Barnett CP, Santos-Simarro F, Pacio-Míguez M, Pozo AD, Bakhtiari S, Deardorff M, Dubbs HA, Izumi K, Grand K, Gray C, Mark PR, Bhoj EJ, Li D, Ortiz-Gonzalez XR, Keena B, Zackai EH, Goldberg EM, Perez de Nanclares G, Pereda A, Llano-Rivas I, Arroyo I, Fernández-Cuesta MÁ, Thauvin-Robinet C, Faivre L, Garde A, Mazel B, Bruel AL, Tress ML, Brilstra E, Fine AS, Crompton KE, Stegmann APA, Sinnema M, Stevens SCJ, Nicolai J, Lesca G, Lion-François L, Haye D, Chatron N, Piton A, Nizon M, Cogne B, Srivastava S, Bassetti J, Muss C, Gripp KW, Procopio RA, Millan F, Morrow MM, Assaf M, Moreno-De-Luca A, Joss S, Hamilton MJ, Bertoli M, Foulds N, McKee S, MacLennan AH, Gecz J, Corbett MA.  Genet Med. 2022 Nov;24(11):2351-2366. doi: 10.1016/j.gim.2022.08.006. Epub 2022 Sep 9. PMID: 36083290.

1. Fatty acids homeostasis during fasting predicts protection from chemotherapy toxicity.
Barradas M, Plaza A, Colmenarejo G, Lázaro I, Costa-Machado LF, Martín-Hernández R, Micó V, López-Aceituno JL, Herranz J, Pantoja C, Tejero H, Diaz-Ruiz A, Al-Shahrour F, Daimiel L, Loria-Kohen V, Ramirez de Molina A, Efeyan A, Serrano M, Pozo OJ, Sala-Vila A, Fernandez-Marcos PJ. Nat Commun. 2022 Sep 27;13(1):5677. doi: 10.1038/s41467-022-33352-3. PMID: 36167809; PMCID: PMC9515185.

1. APPRIS principal isoforms and MANE Select transcripts define reference splice variants. 
Pozo F, Rodriguez JM, Martínez Gómez L, Vázquez J, Tress ML. Bioinformatics. 2022 Sep 16;38(Supplement_2):ii89-ii94. doi: 10.1093/bioinformatics/btac473. PMID: 36124785; PMCID: PMC9486585.

1. Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs.
Jutzi JS, Marneth AE, Ciboddo M, Guerra-Moreno A, Jiménez-Santos MJ, Kosmidou A, Dressman JW, Liang H, Hamel R, Lozano P, Rumi E, Doench JG, Gotlib J, Krishnan A, Elf S, Al-Shahrour F, Mullally A. Blood. 2022 Sep 15;140(11):1291-1304. doi: 10.1182/blood.2022015629. PMID: 35763665; PMCID: PMC9479036.

1. Activation of the integrated stress response is a vulnerability for multidrug-resistant FBXW7-deficient cells.
Sanchez-Burgos L, Navarro-González B, García-Martín S, Sirozh O, Mota-Pino J, Fueyo-Marcos E, Tejero H, Antón ME, Murga M, Al-Shahrour F, Fernandez-Capetillo O. EMBO Mol Med. 2022 Sep 7;14(9):e15855. doi: 10.15252/emmm.202215855. Epub 2022 Jul 21. PMID: 35861150; PMCID: PMC9449593.

1. Mitochondrial RNA methyltransferase TRMT61B is a new, potential biomarker and therapeutic target for highly aneuploid cancers. 
Martín A, Epifano C, Vilaplana-Marti B, Hernández I, Macías RIR, Martínez-Ramírez Á, Cerezo A, Cabezas-Sainz P, Garranzo-Asensio M, Amarilla-Quintana S, Gómez-Domínguez D, Caleiras E, Camps J, Gómez-López G, Gómez de Cedrón M, Ramírez de Molina A, Barderas R, Sánchez L, Velasco-Miguel S, Pérez de Castro I. Cell Death Differ. 2022 Jul 22. doi: 10.1038/s41418-022-01044-6. Epub ahead of print. PMID: 35869285.

1. Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC.
Rogado J, Pozo F, Troule K, Sánchez-Torres JM, Romero-Laorden N, Mondejar R, Donnay O, Ballesteros A, Pacheco-Barcia V, Aspa J, Al-Shahrour F, Alfranca A, Colomer R. Cancers (Basel). 2022 Jun 12;14(12):2898. doi: 10.3390/cancers14122898. PMID: 35740564; PMCID: PMC9221141.

1. An in silico analysis identifies drugs potentially modulating the cytokine storm triggered by SARS-CoV-2 infection.
Sanchez-Burgos L, Gómez-López G, Al-Shahrour F, Fernandez-Capetillo O. Sci Rep. 2022 Jan 31;12(1):1626. doi: 10.1038/s41598-022-05597-x. PMID: 35102208; PMCID: PMC8803893.

1. IL-1 mediates microbiome-induced inflammaging of hematopoietic stem cells in mice
Kovtonyuk LV, Caiado F, Garcia-Martin S, Manz EM, Helbling P, Takizawa H, Boettcher S, Al-Shahrour F, Nombela-Arrieta C, Slack E, Manz MG. IL-1 mediates microbiome-induced inflammaging of hematopoietic stem cells in mice. Blood. 2022 Jan 6;139(1):44-58. doi: 10.1182/blood.2021011570. PMID: 34525198.

1. Endothelial Cell RNA-Seq Data: Differential Expression and Functional Enrichment Analyses to Study Phenotypic Switching. 
Pinel GD, Horder JL, King JR, McIntyre A, Mongan NP, López GG, Benest AV.  
Methods Mol Biol. 2022;2441:369-426. doi: 10.1007/978-1-0716-2059-5_29. PMID: 35099752.
